The role of transient receptor potential channel blockers in human gastric cancer cell viability

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 2, 2012, Pages 175-186

  Kim, Byung Joo ^a   Kim, Sung Young ^b   Lee, Sanghoon ^c   Jeon, Ju Hong ^b   Matsui, Hirofumi ^d   Kwon, Young Kyu ^a   Kim, Seon Jeong ^e   So, Insuk ^b  

^a Pusan National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e Hanyang University   (South Korea)

Author keywords

5 lipoxygenase inhibitors; 9 phenanthrol; Gastric cancer cell; PYR3; TRPM7

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 9 PHENANTHROL; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE INHIBITOR; DOCEBENONE; ENZYME INHIBITOR; NORDIHYDROGUAIARETIC ACID; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL M4; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; UNCLASSIFIED DRUG; ZILEUTON;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; ARACHIDONATE 5-LIPOXYGENASE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEK293 CELLS; HUMANS; LIPOXYGENASE INHIBITORS; MEMBRANE POTENTIALS; STOMACH NEOPLASMS; TIME FACTORS; TRANSFECTION; TRPC CATION CHANNELS; TRPM CATION CHANNELS;

EID: 84863127074     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y11-114     Document Type: Article

References (27)

1. Aarts, M., Iihara, K., Wei, W.L., Xiong, Z.G., Arundine, M., Cerwinski, W., et al. 2003. A key role for TRPM7 channels in anoxic neuronal death. Cell, 115(7): 863-877. doi:10.1016/S0092-8674(03)01017-1. PMID:14697204.
2. Chen, H.C., Xie, J., Zhang, Z., Su, L.T., Yue, L., and Runnels, L.W. 2010. Blockade of TRPM7 channel activity and cell death by inhibitors of 5-lipoxygenase. PLoS ONE, 5(6): e11161. doi:10.1371/journal.pone.0011161. PMID:20567598.
3. Clark, K., Langeslag, M., van Leeuwen, B., Ran, L., Ryazanov, A.G., Figdor, C.G., et al. 2006. TRPM7, a novel regulator of actomyosin contractility and cell adhesion. EMBO J. 25(2): 290-301. doi:10.1038/sj.emboj.7600931. PMID:16407977.
4. Elizondo, M.R., Arduini, B.L., Paulsen, J., MacDonald, E.L., Sabel, J.L., Henion, P.D., et al. 2005. Defective skeletogenesis with kidney stone formation in dwarf zebrafish mutant for trpm7. Curr. Biol. 15(7): 667-671. doi:10.1016/j.cub.2005.02.050. PMID:15823540.
5. Gonzales, A.L., Garcia, Z.I., Amberg, G.C., and Earley, S. 2010. Pharmacological inhibition of TRPM4 hyperpolarizes vascular smooth muscle. Am. J. Physiol. Cell Physiol. 299(5): C1195-C1202. doi:10.1152/ajpcell.00269.2010. PMID:20826763.
6. 2+ mobilization. Trends Neurosci. 16(9): 371-376. doi:10.1016/0166-2236(93)90095-4. PMID:7694408.
7. 2+ handling and cytotoxicity in human prostate cancer cells. Life Sci. 75(19): 2341-2351. doi:10.1016/j.lfs.2004.04.043. PMID:15350831.
8. 2+ level and viability in PC3 human prostate cancer cells. Basic Clin. Pharmacol. Toxicol. 104 (6): 441-447. doi:10.1111/j.1742-7843.2009.00413.x. PMID:19371256.
9. Inoue, K., Branigan, D., and Xiong, Z.G. 2010. Zinc-induced neurotoxicity mediated by transient receptor potential melastatin 7 channels. J. Biol. Chem. 285(10): 7430-7439. doi:10.1074/jbc.M109.040485. PMID:20048154.
10. 2+]i increases in MDCK cells. Life Sci. 66(18): 1753-1762. doi:10.1016/S0024-3205(00)00498-7. PMID:10809172.
11. 2+ homeostasis. Science, 322(5902): 756-760. doi:10.1126/science.1163493.PMID:18974357.
12. Kim, B.J., Lim, H.H., Yang, D.K., Jun, J.Y., Chang, I.Y., Park, C.S., et al. 2005. Melastatin-type transient receptor potential channel 7 is required for intestinal pacemaking activity. Gastroenterology, 129(5): 1504-1517. doi:10.1053/j.gastro.2005.08.016. PMID:16285951.
13. Kim, B.J., Park, E.J., Lee, J.H., Jeon, J.H., Kim, S.J., and So, I. 2008. Suppression of transient receptor potential melastatin 7 channel induces cell death in gastric cancer. Cancer Sci. 99(12): 2502-2509. doi:10.1111/j.1349-7006.2008.00982.x. PMID:19032368.
14. Kim, B.J., Nam, J.H., and Kim, S.J. 2011. Effects of transient receptor potential channel blockers on pacemaker activity in interstitial cells of Cajal from mouse small intestine. Mol. Cells, 32 (2): 153-160. doi:10.1007/s10059-011-1019-1. PMID:21607648.
15. Kiyonaka, S., Kato, K., Nishida, M., Mio, K., Numaga, T., Sawaguchi, Y., et al. 2009. Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound. Proc. Natl. Acad. Sci. U.S.A. 106(13): 5400-5405. doi:10.1073/pnas.0808793106. PMID:19289841.
16. Krapivinsky, G., Mochida, S., Krapivinsky, L., Cibulsky, S.M., and Clapham, D.E. 2006. The TRPM7 ion channel functions in cholinergic synaptic vesicles and affects transmitter release. Neuron, 52(3): 485-496. doi:10.1016/j.neuron.2006.09.033.PMID:17088214.
17. Monteilh-Zoller, M.K., Hermosura, M.C., Nadler, M.J., Scharenberg, A.M., Penner, R., and Fleig, A. 2003. TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions. J. Gen. Physiol. 121(1): 49-60. doi:10.1085/jgp.20028740. PMID:12508053.
18. Nadler, M.J.S., Hermosura, M.C., Inabe, K., Perraud, A.L., Zhu, Q., Stokes, A.J., et al. 2001. LTRPC7 is a MgNATP-regulated divalent cation channel required for cell viability. Nature, 411(6837): 590-595. doi:10.1038/35079092. PMID:11385574.
19. Oancea, E., Wolfe, J.T., and Clapham, D.E. 2006. Functional TRPM7 channels accumulate at the plasma membrane in response to fluid flow. Circ. Res. 98(2): 245-253. doi:10.1161/01.RES.0000200179.29375.cc. PMID:16357306.
20. Ooi, C.H., Ivanova, T., Wu, J., Lee, M., Tan, I.B., Tao, J., et al. 2009. Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet. 5(10): e1000676. doi:10.1371/journal.pgen.1000676. PMID:19798449.
21. Rempe, D.A., Takano, T., and Nedergaard, M. 2009. TR(I)Pping towards treatment for ischemia. Nat. Neurosci. 12(10): 1215-1216. doi:10.1038/nn1009-1215. PMID:19783978.
22. Runnels, L.W., Yue, L., and Clapham, D.E. 2001. TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science, 291(5506): 1043-1047. doi:10.1126/science.1058519.PMID:11161216.
23. 2+ homeostasis by TRPM7. Cell, 114(2): 191-200. doi:10.1016/S0092-8674(03)00556-7. PMID:12887921.
24. Su, L.T., Agapito, M.A., Li, M., Simonson, W.T., Huttenlocher, A., Habas, R., et al. 2006. TRPM7 regulates cell adhesion by controlling the calcium-dependent protease calpain. J. Biol. Chem. 281(16): 11260-11270. doi:10.1074/jbc.M512885200. PMID:16436382.
25. Sun, H.S., Jackson, M.F., Martin, L.J., Jansen, K., Teves, L., Cui, H., et al. 2009. Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia. Nat. Neurosci. 12(10): 1300-1307. doi:10.1038/nn.2395. PMID:19734892.
26. 2+. Pharmacol. Toxicol. 89(6): 301-305. doi:10.1034/j.1600-0773.2001.d01-164.x. PMID:11903955.
27. 2+-activated Cl-conductance in interstitial cells of Cajal linked to slow wave currents and pacemaker activity. J. Physiol. 587(20): 4905-4918. doi:10.1113/jphysiol.2009.176206. PMID:19703958.